Surprisingly, they identified that blockade of PD-L1, CD47, and IL-6 significantly alleviated the severity of pulmonary fibrosis not only in bleomycin-induced pulmonary fibrosis mice model but in IL-6 knockout and humanized NSG mice models. Here, IL6 is linked to pulmonary fibrosis.